drug

marstacimab-hncq

1 story · latest Aug 14, 2026

Status: FDA approved Oct 2024 · BLA761369
Brand: Hympavzi
Code: PF-06741086
Trials: 4 registered trials in coverage

Relationships

Developed by Pfizer

Also known as

marstacimab

Timeline

Pfizer posts hemophilia results, opens eczema Phase 3, ends two skin studies early

Aug 14Weekly roundup, 6 itemsmarstacimab-hncq PF-06823859

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.